Table 1.
Alzheimer’s Disease | |||
---|---|---|---|
Drosophila Model | Developmental Stage | Assay Used for Neuropathology | References |
Drosophila orthologs of human genes | |||
Pan–neuronal and photoreceptor–specific expression of Drosophila dBACE and APPL to produce dAβ | Adult | Toluidine blue histological staining for retinal degeneration, Thioflavin S staining for amyloid deposits, immunohistochemistry using anti–dAβ, fast phototaxis assay, TEM for fibrillary aggregates formation and degeneration | [40] |
APPL null mutants | Adult | Histology for brain morphology, fast phototaxis assay, olfactory acuity assay, shock reactivity assay, odor conditioning assay, optomotor assay | [64] |
Overexpression of human transgenes | |||
Pan–neuronal and photoreceptor–specific expression of Aβ40 and Aβ42 fused to rat pre–proenkephalin signal peptide (SP) | Larva, Adult | Larvae: immunostaining and confocal microscopy for Aβ42 accumulation in imaginal eye discs Adult: SEM and light stereomicroscopy for eye morphology, lifespan, immunostaining with anti–Aβ (6E10) for Aβ42 accumulation, toluidine blue histological staining for ommatidial organization |
[41] |
Pan–neuronal expression of Aβ40, Aβ42 and Aβ42arc fused to Drosophila Necrotic protein SP | Adult | Lifespan, climbing assay, immunostaining with anti–Aβ (4G8) for Aβ42 accumulation, SEM for eye morphology | [42] |
Photoreceptor–specific and mushroom body–specific expression of Aβ42 fused to Drosophila Argos SP | Adult | Light microscopy and SEM for retina structure, light microscopic histology of frontal eye sections for vacuolar degeneration, immunostaining and Thioflavin S staining for Aβ42 accumulation in eyes | [43] |
Photoreceptor–specific expression of Aβ42 and blocking | Larva, Pupa, Adult | 3rd Instar Larvae: immunostaining for eye imaginal disc development and Aβ42 accumulation, TUNEL staining for eye imaginal disc cell death, Pupae: immunostaining for eye development and Aβ42 accumulation Adult: immunostaining for eye development and Aβ42 accumulation, histology for photoreceptor morphology, SEM for eye morphology, |
[44] |
Expression of various mutated Aβ42 peptides for the effect of specific amino acid substitutions on toxicity | Adult | Lifespan, locomotor assay, immunohistochemistry using anti– Aβ42, Thioflavin T staining for rates of Aβ42 aggregation, TEM for Aβ42 aggregate morphology | [45] |
Expression of various mutated Aβ42 peptides for the effect of specific amino acid substitutions on toxicity | Adult | Lifespan | [46] |
Pan–neuronal and muscle–specific expression of Aβ42, exposure to exogenous Aβ42, and treatment with anti–Aβ42 antibody (6E10) | Larva | 3rd Instar Larvae: Electrophysiology for synaptic transmission, FM1–43 dye imaging for neurotransmitter release, Thioflavin S staining for amyloid deposits | [47] |
Pan–neuronal and photoreceptor–specific expression of two human Tau variants, manipulation of light exposure | Adult | Lifespan, histology, and light microscopy to quantify neurodegeneration, climbing assay, immunohistochemistry for pTau accumulation, light microscopy for eye morphology | [48] |
Pan–neuronal expression of human APP and BACE1 separately and in combination, treatment with a γ–secretase inhibitor | Adult | Lifespan, fluorescence microscopy for defects in the whole–brain and mushroom body structure, immunostaining with anti– Aβ (6E10), Thioflavin S, and X–34 for amyloid deposition, climbing assay, conditioned courtship suppression assay | [57] |
Expression of human BACE1 and late–onset induction of human APP | Adult | Lifespan, climbing assay, immunostaining with anti–Aβ (6E10) for amyloid deposition, fluorescence microscopy for defects in the whole–brain and mushroom body structure, conditioned courtship suppression assay | [58] |
Combined models of Drosophila orthologs and overexpression of human transgenes | |||
Knockdown of orthologs of human CD2AP, SNRPN, PTPRD, XYLT1, FERMT2, CELF1, ITGAM, ITGA9, MAST4 in Drosophila overexpressing human TauV337M | Adult | Light microscopy for eye morphology | [39] |
Expression of Drosophila Psn, Drosophila APPL, human APP, and human BACE, separately and in combination | Adult | Histological staining for retinal degeneration, Thioflavin S and immunostaining with anti– Aβ (4G8) for Aβ accumulation in retinas, survival assay, lifespan | [20] |
Aβ42arc overexpression, Draper inhibition, overexpression of Draper/MEGF10 | Adult | Lifespan, Thioflavin S and anti–Aβ (6E10) immunostaining for Aβ, climbing assay, histological sectioning for vacuole quantification | [38] |
Photoreceptor–specific expression of human Aβ42 in eyes, supplementation with zinc or copper, treatment with chelators, and overexpression of MTF–1 | Larva, Adult | Larva: relative eclosion rate Adults: Stereomicroscopy for ommatidia structure, climbing assay |
[50] |
Pan–neuronal expression of Aβ42, treatment with an iron chelator, and RNAi knockdown of ferritin | Embryo, Adult | Embryos: Hatching efficiency assay Adults: Survival assay, Thioflavin T staining for amyloid aggregation |
[49] |
Photoreceptor–specific Aβ42 expression, over– and under–expression of an immunophilin, mutation in a copper transporter, and treatment with an exogenous copper chelator | Adult | Lifespan, light microscopy for eye morphology | [51] |